Spectral Diagnostics Inc. Ships Innovative i-Lynx'TM' Connectivity Instrument

Abstract

Spectral is a developer of innovative technologies for comprehensive disease management. Spectral provides accurate and timely information to clinicians enabling the early initiation of appropriate and targeted therapy. Current products are rapid format tests measuring markers of myocardial infarction (Cardiac STATus(R)). New products include rapid diagnostics for sepsis (the Endotoxin Activity Assay). Spectral manufactures the EAATM and Cardiac STATus(R). Spectral's common shares are listed on The Toronto Stock Exchange: SDI.